Notably, IL1A expression was increased in MDS patients compared to health controls, while TNFRSF1A, PPID, PLA2G4A, MLKL, TNFSF10, FAS, JAK2, STAT1, STAT3, IRF9, USP21, and BAX expression levels were decreased. The gene discussed is IL1A; the disease is myelodysplastic syndrome.